US Bancorp
TYRA icon

US Bancorp’s Tyra Biosciences TYRA Stock Holding History

US Bancorp’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$421 Buy
+11
New +$356 ﹤0.01% 4019
2025
Q3 		– Sell
-7,561
Closed -$72.4K – 4290
2025
Q2 		$72.4K Buy
7,561
+2,126
+39% +$20.2K ﹤0.01% 2603
2025
Q1 		$50.5K Buy
5,435
+1,823
+50% +$23.6K ﹤0.01% 2740
2024
Q4 		$50.2K Buy
+3,612
New +$65.5K ﹤0.01% 2737

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

US Bancorp's TYRA Position: Q1 2026 in Review

US Bancorp opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 11 shares worth $421. The stake represents ﹤0.01% of the portfolio and ranks #4019 among its holdings. This is a return to the name: US Bancorp previously reported a position in TYRA as recently as Q2 2025.

US Bancorp first reported a position in TYRA in Q4 2024 and has held it in 4 quarters since. The position peaked at $72.4K in Q2 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • US Bancorp held 11 shares of Tyra Biosciences worth $421 as of Q1 2026.
  • Tyra Biosciences was a new US Bancorp position in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #4019 holding.
  • US Bancorp first reported a position in Tyra Biosciences in Q4 2024 and has held it in 4 quarters since.
  • US Bancorp's Tyra Biosciences position peaked at $72.4K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.